boilermaker55
Gold Member
- Aug 12, 2011
- 6,890
- 774
- 155
In the article it states that these companies are spending up to 60% on advertisement.
Seems that kind of puts to rest the phony claim about recouping their money from R&D.
he biggest game at this year's Super Bowl didn't take place on the field. It was played out during the commercial breaks when three pharmaceutical commercials took to the air.
But those costly TV spots -- for issues including irritable bowel syndrome and toenail fungus -- represented just a fraction of the $5.2 billion in annual advertising spending from the drug industry. With that figure jumping 60 percent during just the last four years, critics are increasingly asking how the boom in pharmaceutical ads may be affecting consumers and the costs they pay for medication.
The issue is also attracting attention from lawmakers and health professionals. In November, the American Medical Association took the unusual step of calling for a ban on pharmaceutical ads. The reason? Doctors believe the surge in drug ads is prompting consumers to demand expensive medications they might not need.
It is time to end their tax break status around advertising.
"About 20 brand-name prescription drugs have at least quadrupled their prices since 2014, while another 60 medications have doubled in the same time."
Then they have up to 4 lobbyists employed for every person in Congress. Which allows them to influence laws in their favor to ripped off the consumer.
"Drugmakers including Pfizer (PFE) and Allergan (AGN) hiked prices in January, boosting some list prices by as much as 42.3 percent. Of course, the most infamous of all came last year, when pharmaceutical CEO Martin Shkreli raised the price of a six-decade-old drug from $13.50 to $750. He claimed he needed to boost the price to bring in new revenue for drug development."
Drug ads: $5.2 billion annually -- and rising
Seems that kind of puts to rest the phony claim about recouping their money from R&D.
he biggest game at this year's Super Bowl didn't take place on the field. It was played out during the commercial breaks when three pharmaceutical commercials took to the air.
But those costly TV spots -- for issues including irritable bowel syndrome and toenail fungus -- represented just a fraction of the $5.2 billion in annual advertising spending from the drug industry. With that figure jumping 60 percent during just the last four years, critics are increasingly asking how the boom in pharmaceutical ads may be affecting consumers and the costs they pay for medication.
The issue is also attracting attention from lawmakers and health professionals. In November, the American Medical Association took the unusual step of calling for a ban on pharmaceutical ads. The reason? Doctors believe the surge in drug ads is prompting consumers to demand expensive medications they might not need.
It is time to end their tax break status around advertising.
"About 20 brand-name prescription drugs have at least quadrupled their prices since 2014, while another 60 medications have doubled in the same time."
Then they have up to 4 lobbyists employed for every person in Congress. Which allows them to influence laws in their favor to ripped off the consumer.
"Drugmakers including Pfizer (PFE) and Allergan (AGN) hiked prices in January, boosting some list prices by as much as 42.3 percent. Of course, the most infamous of all came last year, when pharmaceutical CEO Martin Shkreli raised the price of a six-decade-old drug from $13.50 to $750. He claimed he needed to boost the price to bring in new revenue for drug development."
Drug ads: $5.2 billion annually -- and rising